MedPath

Prolonged muscle protein synthetic response to the ingestion of a large amount of protei

Conditions
ot applicable
Registration Number
NL-OMON22927
Lead Sponsor
ot applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

Male
-Aged between 18-40 years
-Healthy
-18.5 = BMI 30 = kg·m-2

Exclusion Criteria

-Smoking
-Sports/exercise > 4 sessions/week
-Lactose intolerant or allergies to milk protein
-A history of neuromuscular problems
-Use of anticoagulation medication
-Recent (<9 months) participation in amino acid tracer (L-[ring-2H5-phenylalanine, L-[ring-2H2]-tyrosine, and [1-13C]-leucine infusion) studies
-Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription acne medications).
-Strict vegetarian (because of standardized Aviko meal)
-Injury or condition that would limit the participant from performing the resistance exercise.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Myofibrillar protein synthesis rates
Secondary Outcome Measures
NameTimeMethod
Whole-body protein kinetics and metabolism, plasma metabolites (e.g. glucose and insulin), 1-13C-phenylalanine incorporation
© Copyright 2025. All Rights Reserved by MedPath